Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
BATF | hg19_v2_chr14_+_75988768_75988826 | -0.20 | 3.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_153521597 Show fit | 10.72 |
ENST00000368712.1
|
S100 calcium binding protein A3 |
|
chr1_-_153521714 Show fit | 9.65 |
ENST00000368713.3
|
S100 calcium binding protein A3 |
|
chr3_-_127455200 Show fit | 9.08 |
ENST00000398101.3
|
monoglyceride lipase |
|
chr15_+_89182156 Show fit | 8.31 |
ENST00000379224.5
|
interferon stimulated exonuclease gene 20kDa |
|
chr15_+_67458357 Show fit | 7.70 |
ENST00000537194.2
|
SMAD family member 3 |
|
chr15_+_89181974 Show fit | 7.45 |
ENST00000306072.5
|
interferon stimulated exonuclease gene 20kDa |
|
chr11_-_102668879 Show fit | 7.26 |
ENST00000315274.6
|
matrix metallopeptidase 1 (interstitial collagenase) |
|
chr15_-_80263506 Show fit | 7.15 |
ENST00000335661.6
|
BCL2-related protein A1 |
|
chr10_+_91087651 Show fit | 7.05 |
ENST00000371818.4
|
interferon-induced protein with tetratricopeptide repeats 3 |
|
chr2_+_152214098 Show fit | 6.96 |
ENST00000243347.3
|
tumor necrosis factor, alpha-induced protein 6 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 22.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
1.6 | 17.5 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
2.9 | 14.4 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.9 | 12.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
1.4 | 9.9 | GO:0033590 | response to cobalamin(GO:0033590) |
0.3 | 8.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.7 | 8.1 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
1.1 | 8.0 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 7.1 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
1.1 | 6.8 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 22.2 | GO:0015030 | Cajal body(GO:0015030) |
1.8 | 14.4 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.0 | 11.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.5 | 10.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 7.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
2.3 | 6.8 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.1 | 6.6 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 6.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 6.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 5.8 | GO:0005769 | early endosome(GO:0005769) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.4 | 22.1 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.2 | 21.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
2.9 | 14.4 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.0 | 12.0 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.3 | 11.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 9.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 7.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 7.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.3 | 7.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.9 | 6.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 22.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 13.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 13.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 13.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 12.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 12.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 9.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.4 | 8.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 8.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 7.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 40.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 19.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 19.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.5 | 14.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 11.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 10.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 9.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 9.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 7.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.4 | 6.8 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |